Seres Leadership Team
Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics.
Seres’ visionary team has been at the forefront of microbiome therapeutics for over a decade.
Seres Therapeutics is a commercial biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome. VOWST (fecal microbiota spores, live-brpk), formerly SER-109, is the first and only FDA-approved orally administered microbiota-based therapeutic indicated to prevent the recurrence of Clostridioides difficile infection (CDI)
OUR PRODUCTS NOW APPROVED VOWSTSeres’ microbiome therapeutics represent an entirely new class of potential medicines with promise across a wide range of diseases.
Over the past decade, Seres has pioneered the translation of microbiome insights into an entirely new class of potential new medicines. Our microbiome therapeutics are consortia of bacteria in oral capsules that are designed to have specific functional pharmacological properties to modify the gut microbiome that are being investigated to see if they are able to treat and prevent disease.
OUR PROGRAMS OUR PLATFORMMake your mark on the medical breakthroughs of tomorrow
At Seres, we’re leading the microbiome revolution — and our most revolutionary asset is our team. We’re courageous and deeply collaborative, and above all we’re passionate about the commitment we’ve made to blaze a new trail for the benefit of patients. Our core values are invested in everything we do at Seres, acting as the guiding principles we believe in to help us deliver on our mission to transform the lives of patients.
INSIDE SERES公司相册
员工视角
-
The Science and Potential of Microbiome Therapeutics
The Science and Potential of Microbiome Therapeutics
作者: Matthew Henn
An explosion of research into the human microbiome in recent decades has found links to many conditions – inflammatory diseases, cancer, allergy…
-
Why a Science-Driven Approach to Regulating the Microbiome May Be Key to GI Health
Why a Science-Driven Approach to Regulating the Microbiome May Be Key to GI Health
作者: Terri Young
The word “bacteria” makes many of us imagine soap scum or spoiling food – “bad” organisms that could potentially harm our health. But in recent years…